12:00 AM
Feb 09, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Hard to Treat Diseases preclinical data

In rats, the combination of ribavirin and tiazofurin attenuated the proliferation of autoreactive T lymphocytes and their infiltration...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >